Skip to content

The Aesthetic Surgery Education and Research Foundation

Newsroom
Defining the extent and limitations of the SMAS-platysma unit Print

The ASERF Scientific Research Committee and Board of Directors are pleased to announce the following grant award:

Researcher: Charlies Thorne, MD

Grant Award: ASERF Interim Grant

Amount Awarded: $11,650

Project Name: Defining the extent and limitations of the SMAS-platysma unit

Project Summary: We believe there are several nuances related to the SMAS-platysma that are currently under-appreciated and the source of much of the current controversy in aesthetic facial rejuvenation. The goal of this study is to elucidate and define comprehensively the SMAS-platysma unit. Specifically, we will: 1) define the exact anatomic relationships of the platysma with key anatomic structures, including the modiolus 2) demonstrate the differences in viscoelastic properties of the SMAS-platysma unit with various surgical techniques 3) delineate the ramifications in the lower neck as a result of various manipulations to the  SMAS-platystma unit

 
Genomic Profiling to Understand the Pathogenesis of BIA-ALCL Print

The ASERF Scientific Research Committee and Board of Directors are pleased to announce the following grant award:

Researcher: Nandu Nairn, MD

Grant Award: ASERF Interim Grant

Amount Awarded: $ 10,000

Project Name: Genomic Profiling to Understand the Pathogenesis of BIA-ALCL

Project Summary:

Hypothesis:
We hypothesize that micro and nano-silica nanoparticles with polyurethane may differentially affect the induction of new biomarkers that can potentially influence the pathogenesis of BIA-ALCL.

Accordingly, we propose following specific aim:  

Specific Aim:
To study the comparative effect of nano, micro, and macro silica gel in combination with the polyurethane on global mRNA profiling in T-Cell. Hypothesis: a) silica and polyurethane is the basic implant materials; b) comparison of different sizes will reveal their physiological implications; c) The mRNA profiling will reveal novel yet unidentified molecular factors associated with the implant materials; d) identification of novel molecular markers specific to implant constituents may lead to better treatment approach in BIA-ALCL.

Significance:
Currently more than 11 million women worldwide have breast implants and this number is continuously increasing. Recent reports of BIA-ALCL can be a significant health concern for women with implants. As such, examination of the molecular basis of BIA-ALCL may reveal specific biomarkers leading to better therapeutic approach.

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 8 of 26


Copyright © 2009-2018 ASERF. 11262 Monarch St., Garden Grove, CA 92841-1441 P: 800-364-2147 F: 562-799-1098